Pulmonary embolism
"PE kills through acute right-ventricular failure: a clot obstructs the pulmonary circulation, RV afterload rises abruptly, and a thin-walled RV dilates and fails. Everything โ the risk score, the imaging, the decision to lyse โ is a way of asking one question: is the right ventricle coping?"
Summarised from Irwin & Rippe's Intensive Care Medicine; with Marino's The ICU Book, Oh's Intensive Care Manual and ESC.PE is the pulmonary end of venous thromboembolism (VTE) (with DVT). Most ICU patients are at high VTE risk; more than half of fatal PEs were never suspected โ so the diagnosis is the hard part.
Who clots
| Stasis | Endothelial injury | Hypercoagulability |
|---|---|---|
| Immobility, ICU stay | Surgery, trauma | Malignancy |
| Long travel, paresis | Central venous catheters | Pregnancy/puerperium, oestrogens |
| Heart failure | Prior DVT | Sepsis, inherited thrombophilia, antiphospholipid |
Thrombophilia is present in up to half of young/idiopathic VTE, but screening rarely changes acute management โ treat the clot, defer thrombophilia work-up.
Is the RV coping? โ this decides treatment
| Category | Haemodynamics | RV dysfunction (imaging) | Troponin |
|---|---|---|---|
| High-risk (massive) | Shock / persistent hypotension / arrest | Yes | Usually + |
| Intermediate-high | Stable | Yes | + |
| Intermediate-low | Stable | One or neither of RV dysfunction / troponin | ยฑ |
| Low-risk | Stable | No (sPESI 0) | โ |
- Haemodynamic instability = cardiac arrest, obstructive shock (SBP <90 or vasopressors + hypoperfusion), or persistent hypotension (SBP <90 or a drop โฅ40 mmHg for >15 min).
- sPESI (each 1 point): age >80, cancer, chronic cardiopulmonary disease, HR โฅ110, SBP <100, SpOโ <90%. Score 0 = low risk.
Confirm it โ pathway depends on stability
Unstable (suspected high-risk)
Don't wait for CT โ bedside echo: RV dilatation/strain supports the diagnosis and justifies reperfusion. CTPA as soon as safe.
Stable
Wells / Geneva pre-test probability โ if unlikely, D-dimer (age-adjusted) to rule out; if likely or D-dimer positive โ CTPA (V/Q if contrast contraindicated).
Supporting tests
ECG (sinus tachy, S1Q3T3, RV strain), ABG (hypoxaemia, โ Aโa), troponin/BNP (RV strain), leg compression ultrasound (DVT).
Treat to the risk
| Category | Treatment |
|---|---|
| High-risk (shock) | Systemic thrombolysis (e.g. alteplase) unless contraindicated; if contraindicated/failed โ catheter-directed therapy or surgical embolectomy. Support: cautious fluids, noradrenaline ยฑ inotrope, Oโ; ECMO as a bridge in extremis. |
| Intermediate-high | Anticoagulate + monitor closely; rescue thrombolysis (or catheter therapy) if they deteriorate. Not routine full-dose lysis. |
| Intermediate-low | Anticoagulation; admit/observe. |
| Low-risk | Anticoagulation; consider early discharge/outpatient (Hestia/sPESI 0). |
Positive-pressure ventilation and induction agents can collapse a failing RV. Avoid intubation if possible; if unavoidable, optimise preload/pressor first, use gentle settings, and avoid fluid overload (a distended RV worsens by bowing the septum).
The backbone of every category
| Agent | Use | Note |
|---|---|---|
| DOAC (apixaban, rivaroxaban) | First line for most | Single-drug; edoxaban/dabigatran need LMWH lead-in |
| LMWH | Cancer, pregnancy, initial therapy | Renally cleared; weight-based |
| UFH infusion | High-risk/unstable, severe renal failure, planned lysis | Titratable, rapidly reversible |
| Warfarin | Antiphospholipid syndrome, valves | Overlap with heparin until INR therapeutic |
Duration: provoked by a transient factor โ ~3 months; unprovoked, recurrent or ongoing risk (cancer, thrombophilia) โ extended/indefinite, reassessing bleeding risk.
Adjuncts & caveats
- IVC filter: only when anticoagulation is contraindicated or PE recurs despite adequate anticoagulation โ not routine.
- Cancer-associated VTE: DOAC or LMWH; watch GI/GU bleeding with DOACs.
- Pregnancy: LMWH (avoid DOAC/warfarin); tailored diagnostic pathway.
- Prophylaxis: almost all ICU patients need pharmacological or mechanical VTE prophylaxis โ prevention beats treatment.
Common mistakes
Over-filling a strained RV worsens septal bowing and cardiac output. Give small, cautious challenges and start noradrenaline early.
Use bedside echo โ RV strain justifies reperfusion when CT isn't safe.
Full-dose lysis in stable intermediate-high PE increases bleeding โ anticoagulate and watch, lyse only if they deteriorate.
A negative D-dimer does not exclude PE when probability is high โ go to imaging.
Most fatal PEs are unsuspected โ VTE prophylaxis for nearly every ICU patient.
Exam pearls
Q: Define high-risk PE.
PE with haemodynamic instability โ cardiac arrest, obstructive shock, or persistent hypotension โ regardless of the imaging.
Q: Intermediate-high vs intermediate-low?
Both stable; intermediate-high has both RV dysfunction on imaging and raised troponin.
Q: When do you thrombolyse?
High-risk PE (shock) unless contraindicated; as rescue in intermediate-high PE that deteriorates.
Q: First-line anticoagulant?
A DOAC for most; UFH infusion if unstable/renal failure/planned lysis; LMWH in cancer/pregnancy.
Q: When is an IVC filter indicated?
Anticoagulation contraindicated, or recurrent PE despite adequate anticoagulation.
All the comparisons in one place
The distinctions that decide reperfusion and answers โ gathered at the end.
High vs Intermediate vs Low-risk PE
| Feature | High-risk | Intermediate | Low-risk |
|---|---|---|---|
| Haemodynamics | Unstable / shock | Stable | Stable |
| RV dysfunction | Yes | ยฑ | No |
| Treatment | Thrombolysis / embolectomy | Anticoagulate ยฑ rescue lysis | Anticoagulate ยฑ early discharge |
Thrombolysis vs Anticoagulation
| Feature | Thrombolysis | Anticoagulation |
|---|---|---|
| Action | Actively dissolves clot | Prevents propagation; body lyses over time |
| Speed | Rapid RV unloading | Gradual |
| Main risk | Major/intracranial bleeding | Bleeding (lower) |
| Indication | High-risk (shock); rescue | All PE โ the backbone |
CTPA vs V/Q scan
| Feature | CTPA | V/Q scan |
|---|---|---|
| Availability/speed | Fast, first-line | Slower, limited hours |
| Best when | Most patients | Contrast allergy, renal failure, pregnancy (low radiation to breast), normal CXR |
| Extras | Alternative diagnoses, RV size | No alternative diagnosis |
References
- Irwin RS, Lilly CM, Mayo PH, Rippe JM (eds). Irwin & Rippe's Intensive Care Medicine. 9th ed. Wolters Kluwer; 2023.
- Marino PL. Marino's The ICU Book. 5th ed. Wolters Kluwer; 2025.
- Bersten AD, Handy JM (eds). Oh's Intensive Care Manual. Elsevier; 2026.
- Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41:543โ603.
- Meyer G, Vicaut E, Danays T, et al. (PEITHO). Fibrinolysis for intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402โ1411.
- Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: CHEST guideline. Chest. 2021;160:e545โe608.